Recommendations and administration of the HPV vaccine to 11- to 12-year-old girls and boys: A statewide survey of georgia vaccines for children provider practices

Journal of Lower Genital Tract Disease

Volumn 18, Issue 4, 2014, Pages 298-303

  Luque, John S ^a   Tarasenko, Yelena N ^a   Dixon, Betty T ^b   Vogel, Robert L ^a   Tedders, Stuart H ^a  

^a GEORGIA SOUTHERN UNIVERSITY   (United States)

^b Coastal Health District ^*  (United States)

Author keywords

Cervical cancer; HPV vaccine; Human papillomavirus; Physicians; Vaccines for Children program

Indexed keywords

WART VIRUS VACCINE;

ADULT; ADVISORY COMMITTEE; ARTICLE; ASIAN; BLACK PERSON; CAUCASIAN; CLINICAL PRACTICE; CONDYLOMA ACUMINATUM; CROSS-SECTIONAL STUDY; ETHNICITY; FAMILY MEDICINE; FEMALE; GYNECOLOGIST; HEALTH CARE SURVEY; HUMAN; INTERNIST; MALE; MEDICAL SOCIETY; MEDICATION COMPLIANCE; PEDIATRICIAN; PHYSICIAN; PROFESSIONAL KNOWLEDGE; REIMBURSEMENT; RESIDENCY EDUCATION; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION; VERRUCA VULGARIS; CHILD; COMPLICATION; GEORGIA; HEALTH CARE PERSONNEL; IMMUNOLOGY; MEDICAL INFORMATION; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; UTILIZATION;

CHILD; CROSS-SECTIONAL STUDIES; FEMALE; GEORGIA; HEALTH COMMUNICATION; HEALTH PERSONNEL; HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE QUADRIVALENT, TYPES 6, 11, 16, 18; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; VACCINATION;

EID: 84915828215     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0000000000000011     Document Type: Article

References (22)

1. Centers for Disease Control and Prevenetion (CDC). Human papillomavirusYassociated cancersVUnited States, 2004-2008. MMWR Morb Mortal Wkly Rep 2012;61:258-61
2. Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 2013;208:385-93
3. CDC. National and state vaccination coverage among adolescents aged 13Y17 yearsVUnited States, 2011. MMWR Morb Mortal Wkly Rep 2012;61:671-7
4. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2007;56:1-24
5. CDC. Recommendations on the use of quadrivalent human papillomavirus vaccine in malesVAdvisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1705-8
6. Allen JD, Coronado GD,Williams RS, Glenn B, Escoffery C, Fernandez M, et al. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine 2010;28:4027-37
7. Javanbakht M, Stahlman S, Walker S, Gottlieb S, Markowitz L, Liddon N, et al. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine 2012;30:4511-6
8. Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics 2011;128:830-9
9. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19Y26: importance of a physician's recommendation. Vaccine 2011;29:890-5
10. Kahn JA, Cooper HP, Vadaparampil ST, Pence BC, Weinberg AD, LoCoco SJ, et al. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: A statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 2009;18:2325-32
11. Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011;29:8634-41
12. Malo TL, Hassani D, Staras SA, Shenkman EA, Giuliano AR, Vadaparampil ST. Do Florida Medicaid providers' barriers to HPV vaccination vary based on VFC program participation? Matern Child Health J 2013;17:609-15
13. Lohr SL. Sampling: Design and Analysis. Boston, MA: Cengage Learning; 2009
14. Vadaparampil ST, Murphy D, Rodriguez M, Malo TL, Quinn GP. Qualitative responses to a national physician survey on HPV vaccination. Vaccine 2013;31:2267-72
15. USDA. Rural-Urban Continuum Codes. 2013. Available at: http:// www.ers.usda.gov/data-products/rural-urban-continuumcodes. aspx#.UcRuuHnJbSh. Accessed June 26, 2013
16. Katz ML, Reiter PL, Heaner S, Ruffin MT, Post DM, Paskett ED. Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine 2009;27:3945-52
17. Ko EM, Missmer S, Johnson NR. Physician attitudes and practice toward human papillomavirus vaccination. J Low Genit Tract Dis 2010;14:339-45
18. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, et al. Human papillomavirus vaccination practices: A survey of US physicians 18 months after licensure. Pediatrics 2010;126:425-33
19. Weiss TW, Zimet GD, Rosenthal SL, Brenneman SK, Klein JD. Human papillomavirus vaccination of males: Attitudes and perceptions of physicians who vaccinate females. J Adolesc Health 2010;47:3-11
20. Gilkey MB, Moss JL, McRee AL, Brewer NT. Do correlates of HPV vaccine initiation differ between adolescent boys and girls? Vaccine 2012;30:5928-34
21. CDC. Vaccines for Children Program. National Center for Immunization and Respiratory Diseases. 2013. Available at: http://www.cdc.gov/ vaccines/programs/vfc/providers/. Accessed July 27, 2013
22. Vadaparampil ST, Staras SA, Malo TL, Eddleton KZ, Christie J, Rodriguez M, et al. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls. Cancer 2013;119:621-8.